Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crescita Therapeutics Inc
(TSX:
CTX
)
0.6700
+0.0300 (+4.69%)
Streaming Delayed Price
Updated: 3:53 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
119,190
Open
0.6400
Bid (Size)
0.6400 (185)
Ask (Size)
0.6700 (160)
Prev. Close
0.6400
Today's Range
0.6400 - 0.6700
52wk Range
0.3600 - 0.7200
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Crescita Reports Second Quarter 2024 Results
August 07, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
July 22, 2024
From
Crescita Therapeutics
Via
Business Wire
Performance
YTD
+36.73%
+36.73%
1 Month
+11.67%
+11.67%
3 Month
+55.81%
+55.81%
6 Month
+52.27%
+52.27%
1 Year
+4.69%
+4.69%
More News
Read More
Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
July 19, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
July 17, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
June 26, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita to Acquire Strategic Assets of Occy Laboratory
June 20, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 06, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports First Quarter 2024 Results
May 08, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Q4 and Fiscal 2023 Results
March 13, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Third Quarter 2023 Results
November 08, 2023
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
August 29, 2023
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Second Quarter 2023 Results
August 09, 2023
From
Crescita Therapeutics
Via
Business Wire
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 21, 2023
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports First Quarter 2023 Results
May 11, 2023
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Reports Q4 and Fiscal 2022 Results
March 15, 2023
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Reports Third Quarter 2022 Results
November 09, 2022
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Reports Second Quarter 2022 Results
August 10, 2022
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
May 12, 2022
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports First Quarter 2022 Results
May 11, 2022
From
Crescita Therapeutics
Via
Business Wire
Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference
April 21, 2022
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Q4 and Fiscal 2021 Results
March 23, 2022
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid
December 15, 2021
From
Crescita Therapeutics
Via
Business Wire
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®
December 13, 2021
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Third Quarter 2021 Results and Appoints New Board Member
November 11, 2021
From
Crescita Therapeutics
Via
Business Wire
Crescita Announces Exclusive Canadian Distribution Agreement with Obagi Cosmeceuticals LLC
September 09, 2021
From
Crescita Therapeutics
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.